Effects of Microbial Metabolites of (-)-Epigallocatechin Gallate on Glucose Uptake in L6 Skeletal Muscle Cell and Glucose Tolerance in ICR Mice.


Journal

Biological & pharmaceutical bulletin
ISSN: 1347-5215
Titre abrégé: Biol Pharm Bull
Pays: Japan
ID NLM: 9311984

Informations de publication

Date de publication:
2019
Historique:
entrez: 5 2 2019
pubmed: 5 2 2019
medline: 10 7 2019
Statut: ppublish

Résumé

Glucose uptake ability into L6 skeletal muscle cell was examined with eleven kinds of ring fission metabolites of (-)-epigallocatechin gallate (EGCG) produced by intestinal bacteria. The metabolites 5-(3,5-dihydroxyphenyl)-γ-valerolactone (EGC-M5), 4-hydroxy-5-(3,4,5-trihydroxyphenyl)valeric acid (EGC-M6), 5-(3,4,5-trihydroxyphenyl)-γ-valerolactone (EGC-M7) and 5-(3-hydroxyphenyl)valeric acid (EGC-M11) have been found to promote uptake of glucose into L6 myotubes significantly. EGC-M5, which is one of the major ring fission metabolites of EGCG, was also found to have a promotive effect on glucose transporter 4 (GLUT4) translocation accompanied by phosphorylation of AMP-activated protein kinase (AMPK) signaling pathway in skeletal muscle both in vivo and in vitro. Furthermore, the effect of oral single dosage of EGC-M5 on glucose tolerance test with ICR mice was examined and significant suppression of hyperglycemia was observed. These data suggested that EGC-M5 has an antidiabetic effect in vivo.

Identifiants

pubmed: 30713253
doi: 10.1248/bpb.b18-00612
doi:

Substances chimiques

5-(3,5-dihydroxyphenyl)-gamma-valerolactone 0
Blood Glucose 0
Hypoglycemic Agents 0
Lactones 0
Catechin 8R1V1STN48
epigallocatechin gallate BQM438CTEL
AMP-Activated Protein Kinases EC 2.7.11.31
Glucose IY9XDZ35W2
gamma-valerolactone O7056XK37X

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

212-221

Auteurs

Akiko Takagaki (A)

Department of Agrobioscience, Graduate School of Agricultural Science, Kobe University.
R&D Group, Mitsui Norin Company, Limited.

Yasukiyo Yoshioka (Y)

Graduate School of Science, Technology and Innovation, Kobe University.

Yoko Yamashita (Y)

Department of Agrobioscience, Graduate School of Agricultural Science, Kobe University.

Tomoya Nagano (T)

Department of Agrobioscience, Graduate School of Agricultural Science, Kobe University.

Masaki Ikeda (M)

Department of Agrobioscience, Graduate School of Agricultural Science, Kobe University.

Aya Hara-Terawaki (A)

R&D Group, Mitsui Norin Company, Limited.

Ryota Seto (R)

R&D Group, Mitsui Norin Company, Limited.

Hitoshi Ashida (H)

Department of Agrobioscience, Graduate School of Agricultural Science, Kobe University.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH